An investigation on causes of delayed referral of patients with pleural empyema
Abstract
Background: In the treatment of pleural empyema, medical therapy is typically sufficient for the 1st or 2nd
stage. However, surgical intervention becomes the optimal modality in the 3rd stage. A significant number of
patients experience delayed diagnosis and treatment, leading to the conversion of non-surgical pleural empyema into complicated surgical empyema.
Methods: A cross-sectional study was conducted on patients with pleural empyema who were admitted to
NRITLD in Tehran from 2015 to 2016. Initially, 66 patients were selected; however, after the exclusion of 12
patients, a total of 54 patients were included in the study.
Results: Delays were attributed to the medical system in 62% of cases and to the patient in 29% of cases. The
median (IQR) of the total delay time attributed to the system was 38 (25) days. No significant difference was
found in the median of delayed referrals between genders. A significant correlation was observed between the
interval of the first and last visit and the interval between the onset of symptoms and chest x-ray (CXR), as well
as the interval between the performance of CXR and the insertion of chest tube drainage (CTD).
Conclusions: The delay in referral and treatment can be attributed to the patient, practitioners, or both. In this
study, it was found that the medical system is the primary cause of delay, primarily due to the long waiting times for admission and operation in hospitals. Patients who experience a delay in CXR and CTD insertion will face a significant delay in referral and their course of treatment. It is suggested that delayed referral could be prevented by providing patients with basic medical education, offering specialized training to general practitioners for early referral, and managing waiting lists effectively.
2. Kiwuwa MS, Charles K, Harriet MK. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health. 2005;5:122. https://doi.org/10.1186/1471-2458-5-122
3. Billing JS, Wells FC. Delays in the Diagnosis and surgical treatment of lung cancer. Thorax. 1996;51(9):903-906.
https://doi.org/10.1136/thx.51.9.903
4. Hsieh VC, Wu TN, Liu SH, Shieh SH. Referral-free health care and delay in diagnosis for lung cancer patients. Jpn J Clin Oncol. 2012;42(10):934-9. https://doi.org/10.1093/jjco/hys113
5. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J. 2004;24(6):898-904. https://doi.org/10.1183/09031936. 04.00113603
6. Singh H, Hirani K, Kadiyala H, et al. Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study. J Clin Oncol. 2010;28(20):3307-15. https://doi.org/10.1200/JCO.2009.25.6636
7. Goodson WH, Moore DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med. 2002;162(12):1343-8. https://doi.org/10.1001/ archinte.162.12.1343
8. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119-26. https://doi.org/10.1016/S0140-6736(99)02143-1
9. Afzelius P, Zedeler K, Sommer H, et al. Patient’s and doctor’s delay in primary breast cancer. Prognostic implications. Acta Oncol. 1994;33(4):345-51. https://doi.org/10.3109/02841869409098427
10. Myrdal G, Lambe M, Hillerdal G, et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004;59(1):45-49.
11. Corner J, Hopkinson J, Fitzsimmons D, et al. Is late diagnosis of lung cancer inevitable? Interview study of patients’ recollections of symptoms before diagnosis. Thorax. 2005;60(4):314-319. https://doi.org/10.1136/thx.2004.029264
12. Cham CW, Haq SM, Rahamim J. Empyema thoracis: a problem with late referral. Thorax. 1993;48(9):925-927. https://doi.org/10.1136/thx.48.9.925
13. Chung JH, Lee SH, Kim KT, et al. Optimal timing of thorachoscopic drainaige and decortication for empyema. Ann Thorac Surg. 2014;97(1):224-9. https://doi.org/10.1016/j.athoracsur.2013.08.039
14. Karoubi MT, Akhondi MM. How Does Iranian’s Legal System Protect Human Vulnerability and Personal Integrity in Medical Research? Avicenna J Med Biotechnol. 2011;3(2):51-9.
Files | ||
Issue | Vol 6 No 1 (2023) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/ajs.v6i1.14713 | |
Keywords | ||
patient referral delayed referral self-treatment pleural empyema |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |